In a Phase 2 clinical trial published in 2023 in the New England Journal of Medicine (Jastreboff et al.), participants receiving the highest dose of retatrutide lost up to approximately 24% of their body weight over 48 weeks a notably greater reduction than observed with currently approved agents
LOW BATCH INVENTORY: Only 0 units remaining Checking dispatch schedule
It's also prescribed off-label for weight loss, but there is another semaglutide medication, Wegovy, that is prescribed specifically for weight loss
This can cause symptoms such as dizziness, confusion, sweating, and even loss of consciousness
It means the brand is describing the product's role in supporting a normal physiological process - in this case, bone mineralization
Load Up on Zinc and Vitamin D Research shows that specific micronutrients may help boost IGF-1